Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding uveitis: the impact of research on visual outcomes.
de Smet MD, Taylor SR, Bodaghi B, Miserocchi E, Murray PI, Pleyer U, Zierhut M, Barisani-Asenbauer T, LeHoang P, Lightman S. de Smet MD, et al. Prog Retin Eye Res. 2011 Nov;30(6):452-70. doi: 10.1016/j.preteyeres.2011.06.005. Epub 2011 Jul 22. Prog Retin Eye Res. 2011. PMID: 21807112 Review.
Sustained-release Corticosteroids for Uveitis.
Cunningham ET Jr, de Smet MD, Yeh S, Albini TA, Zierhut M. Cunningham ET Jr, et al. Among authors: de smet md. Ocul Immunol Inflamm. 2015;23(6):421-4. doi: 10.3109/09273948.2015.1114778. Ocul Immunol Inflamm. 2015. PMID: 26652837 No abstract available.
COVID-19: Limiting the Risks for Eye Care Professionals.
Sadhu S, Agrawal R, Pyare R, Pavesio C, Zierhut M, Khatri A, Smith JR, de Smet MD, Biswas J. Sadhu S, et al. Among authors: de smet md. Ocul Immunol Inflamm. 2020 Jul 3;28(5):714-720. doi: 10.1080/09273948.2020.1755442. Epub 2020 Apr 20. Ocul Immunol Inflamm. 2020. PMID: 32310028 Review.
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.
Thng ZX, De Smet MD, Lee CS, Gupta V, Smith JR, McCluskey PJ, Thorne JE, Kempen JH, Zierhut M, Nguyen QD, Pavesio C, Agrawal R. Thng ZX, et al. Among authors: de smet md. Br J Ophthalmol. 2021 Mar;105(3):306-310. doi: 10.1136/bjophthalmol-2020-316586. Epub 2020 Jun 12. Br J Ophthalmol. 2021. PMID: 32532764 Free PMC article. Review.
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
Agrawal R, Testi I, Lee CS, Tsui E, Blazes M, Thorne JE, Okada AA, Smith JR, McCluskey PJ, Kempen JH, Tappeiner C, Agarwal M, Bodaghi B, Nguyen QD, Gupta V, De Smet MD, Zierhut M, Pavesio C; COVID-19 IMT Study Group. Agrawal R, et al. Among authors: de smet md. Br J Ophthalmol. 2021 May;105(5):639-647. doi: 10.1136/bjophthalmol-2020-316776. Epub 2020 Jun 25. Br J Ophthalmol. 2021. PMID: 32586933 Free PMC article.
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Among authors: de smet md. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
Expert opinion on the management and follow-up of uveitis patients during SARS-CoV-2 outbreak.
Stanescu-Segall D, Sales de Gauzy T, Reynolds R, Faes L, Pohlmann D, Pakzad-Vaezi K, Ting D, Saadoun D, Ambati J, Loewenstein A, Bodaghi B, de Smet MD, Touhami S. Stanescu-Segall D, et al. Among authors: de smet md. Expert Rev Clin Immunol. 2020 Jul;16(7):651-657. doi: 10.1080/1744666X.2020.1791086. Epub 2020 Jul 21. Expert Rev Clin Immunol. 2020. PMID: 32615046
196 results